ENBREL (etanercept) Patient Assistance Program
Don’t let the high cost of Enbrel disrupt your treatment. The Amgen Safety Net Foundation provides Enbrel free of charge to eligible patients — and we manage your entire enrollment for a flat $69.95 per month
- Clear & Transparent Pricing
- Paperwork, Documentation & Doctor-Coordination Handled For You
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Guidance — Enbrel’s Negotiated Part D Price Took Effect January 2026
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Enbrel (Etanercept) Is FDA-Approved For Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, And Polyarticular Juvenile Idiopathic Arthritis. It Is A TNF-Blocker Self-Injected Weekly, Which Means It Is Covered Under Medicare Part D — Not Part B.
- Without Assistance, Enbrel’s Cash Price Runs Roughly $2,000 Per 50 mg Syringe — Over $8,000 For A Month Of Weekly Doses. The Amgen Safety Net Foundation Provides Enbrel Free To Eligible Patients For Up To 12 Months Per Enrollment.
- Medicare Changed Everything In 2026: Enbrel Was In The First Round Of Medicare Drug Price Negotiation, And Its Negotiated Price Of $2,355 Per 30-Day Supply — A 67% Cut — Took Effect January 1, 2026. Combined With The $2,100 Part D Out-Of-Pocket Cap, Medicare Patients’ Annual Costs Are Now Dramatically Lower.
- Two Enbrel Biosimilars (Erelzi, Eticovo) Are FDA-Approved But Neither Is Sold In The U.S. — Patent Rulings Block Them Until Around 2029. Until Then, Assistance Programs Are The Realistic Path To Affordability.
What is Enbrel Prescription Assistance Program?
The Enbrel Patient Assistance Program is run by the Amgen Safety Net Foundation, the manufacturer’s nonprofit patient-assistance arm, and provides Enbrel at no medication cost to qualifying patients. It is designed for people who have no insurance coverage for Enbrel and meet the foundation’s income limits — currently $47,880 for a household of one and $64,920 for two, adding $17,040 for each additional person. Enrollment lasts up to 12 months, with annual re-enrollment. Applying directly through the Amgen Safety Net Foundation (1-800-932-3060, Mon–Fri 8 AM–8 PM ET) is always free. The hard part is everything around the form: eligibility verification, income documentation, prescriber coordination, denial appeals, and renewal deadlines — and for commercially insured patients, choosing correctly between the free-drug program and the Enbrel Co-Pay Card. For a flat $69.95 per month, our Patient Advocates handle every step, from initial application through refills and re-certification.
Pharmacy Price Comparison
- Without assistance, Enbrel costs thousands of dollars per month at retail and specialty pharmacies. Discount cards and pharmacy coupons offer some relief, but they don't come close to what a Patient Assistance Program provides if you qualify. The table below compares typical retail pricing across major pharmacies to what you'd pay with our Enbrel advocacy service:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$8,200/mo | Save substantially |
| CVS Pharmacy(brand) | ~$8,500/mo | Save substantially |
| Walmart (brand) | ~$6,400/mo | Save substantially |
| Specialty pharmacy (brand) | ~$6,000/mo | Save substantially |
| Etanercept biosimilars (Erelzi/Eticovo) | ~$3,500–$5,500/mo | Biosimilar — substantial |
Just a heads-up — cash prices are estimates from public pricing data and vary by pharmacy. Enbrel is self-injected, so Medicare covers it under Part D, where the $2,100 annual out-of-pocket cap (2026) now applies — a major change from years past.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Enbrel Prescription Program?
The Amgen Safety Net Foundation program is free to apply for and provides Enbrel at no medication cost if approved. Our $69.95/month service covers full advocacy — for patients who want an experienced team managing the process end-to-end, especially with multiple medications, prior denials, or Medicare transitions.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Enbrel:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
Coupon cards expire and require constant renewal
- Still $6,000–$8,500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly from the manufacturer
- We manage all paperwork, refills, and renewals
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
The Amgen Safety Net Foundation publishes clear eligibility rules for free Enbrel. You will generally qualify if all of the following are true — and if your situation doesn’t fit neatly, contact AffordMyPrescriptions so we can review your case and determine if you qualify for Enbrel assistance:
- You Have Lived In The U.S. Or A U.S. Territory For At Least 6 Months
- You Have A Valid Enbrel Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- Your Household Income Is At Or Below $47,880 (1 Person) Or $64,920 (2 People), Plus $17,040 Per Additional Person
Understanding Enbrel:
Enbrel (etanercept) is a TNF receptor fusion protein — a soluble “decoy receptor” that binds and neutralizes TNF-alpha, an inflammatory signaling protein that drives autoimmune conditions like rheumatoid arthritis and psoriasis. By soaking up excess TNF, Enbrel reduces the inflammation that damages joints and skin.
How Enbrel Works:
In autoimmune diseases, the immune system produces too much TNF-alpha, triggering chronic inflammation in joints, skin, and connective tissue. Enbrel acts as a decoy: it binds circulating TNF before it can reach the receptors on your cells, interrupting the inflammatory cascade. It doesn’t cure the underlying disease, but it can substantially slow joint damage and clear skin symptoms with consistent weekly use — which is exactly why uninterrupted access matters so much.
Form and Use:
Enbrel is self-injected subcutaneously, typically 50 mg once weekly for adults, using a prefilled syringe, SureClick autoinjector, or Enbrel Mini cartridge. Because it is self-administered at the pharmacy benefit level, Medicare covers it under Part D — which since January 2026 means both a negotiated price ($2,355 per 30-day supply, down 67% from list) and a hard $2,100 annual out-of-pocket cap. Many Medicare patients who abandoned Enbrel over cost in past years should re-check their numbers now.
Generic Availability:
FDA-approved etanercept biosimilars: Erelzi (etanercept-szzs) and Eticovo (etanercept-ykro) — substantially cheaper than brand Enbrel. Other TNF inhibitors: adalimumab (Humira with many biosimilars since 2023, including interchangeable Cyltezo and Simlandi), infliximab (Remicade with biosimilars Inflectra, Renflexis, Avsola, Ixifi), certolizumab (Cimzia — no biosimilar yet), golimumab (Simponi and Simponi Aria — no biosimilar yet). Generic DMARDs first-line per ACR guidelines: methotrexate (oral and SC), sulfasalazine, hydroxychloroquine, leflunomide. JAK inhibitors: Rinvoq (upadacitinib), Olumiant (baricitinib), Xeljanz (tofacitinib — generic now available). Biologics by indication: IL-6 (Actemra/tocilizumab with biosimilars, Kevzara/sarilumab), abatacept (Orencia), IL-23 (Skyrizi, Tremfya, Stelara with biosimilars), IL-17 (Cosentyx, Taltz, Bimzelx). Oral psoriasis options: Otezla (apremilast — generic now), Sotyktu (deucravacitinib).
Warnings:
Enbrel carries a boxed warning for serious infections, including tuberculosis and invasive fungal infections, and for lymphoma and other malignancies reported in children and adolescents. Patients should be tested for TB before starting, promptly report fevers or persistent infections, and avoid live vaccines during treatment. Tell your prescriber about any history of heart failure, hepatitis B, or nervous-system disease before starting.
FAQ (Frequently Asked Questions)
How Much Does Enbrel Cost Without Insurance?
Cash prices run roughly $2,000 per 50 mg syringe — over $8,000 per month at the standard weekly dose. Uninsured patients who meet the income limits can receive Enbrel free through the Amgen Safety Net Foundation; our $69.95 monthly fee covers full advocacy and enrollment management.
What Is A TNF Blocker?
TNF blockers are biologic drugs that neutralize tumor necrosis factor alpha, a protein that drives inflammation in autoimmune diseases. Enbrel was one of the first, approved in 1998, and works as a decoy receptor rather than an antibody — one reason its dosing and immune profile differ from drugs like Humira or Simponi.
Does Medicare Cover Enbrel?
Yes — under Part D, because it’s self-injected. And 2026 is a turning point: Enbrel’s Medicare-negotiated price of $2,355 per 30-day supply took effect January 1, 2026 (67% below its former list price), and the Part D out-of-pocket cap limits your total annual drug spending to $2,100. If Enbrel’s cost drove your decisions in past years, it’s worth re-running the numbers now.
Can I Use The Enbrel Co-Pay Card With Medicare?
No. The Enbrel Co-Pay Card is restricted to commercially insured patients — federal rules exclude Medicare, Medicaid, and other government programs. Medicare patients rely on the negotiated price and the Part D cap instead; low-income Medicare patients should also check Extra Help (the Low-Income Subsidy).
Is There A Generic Or Biosimilar For Enbrel?
Not in the U.S. — Erelzi and Eticovo are FDA-approved biosimilars, but patent rulings keep them off the market until around 2029. There is no cheaper substitute to switch to today.
How Long Does Amgen Safety Net Foundation Approval Last?
Up to 12 months per enrollment, with re-enrollment required annually. We track your renewal date and re-file before coverage lapses, so treatment isn’t interrupted.
What If My Application Is Denied?
Denials are usually about documentation — missing income proof, an insurance-status mismatch, or incomplete prescriber sections. Applications can be corrected and resubmitted. We review the denial letter, fix what triggered it, and resubmit on your behalf.
Take Control of Your Medication Costs
Amgen’s assistance program can make Enbrel free if you qualify — and Medicare’s 2026 negotiated price changed the math for millions of patients. Check your eligibility today; the pre-qualification review is free, and if we can’t help you, you pay nothing.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.